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The present study was to evaluate the toxicity and immunomodulatory effects of 
damnacanthal, nordamnacanthal, betulinic acid and zerumbone isolated from local  
medicinal plants towards leukemia cell lines and immune cells. Toxicity study was 
performed on HL-60 (Human acute promyelocytic leukemia), CEM-SS (Human T-
lymphoblastic leukemia), WEHI-3B (Mouse myelomonocyte leukemia), 3T3 
(Mouse embryo fibroblast) and human peripheral blood mononuclear cell (PBMC) 
by using MTT assay and cell cycle analysis. The results showed that damnacanthal 
significantly inhibited HL-60 cells, CEM-SS and WEHI-3B with the IC50 value of 
4.0 µg/mL, 8.0 µg/mL and 3.3 µg/mL, respectively. Nordamnacanthal and betulinic 
acid showed stronger inhibition towards CEM-SS and HL-60 cells with the IC50 
value of 5.7 µg/mL and 5.0 µg/mL, respectively. In contrast, Zerumbone was 
demonstrated to be more toxic towards those leukemia cells with the IC50 value less 
than 10 µg/mL. Interestingly, damnacanthal, nordamnacanthal and betulinic acid 
iii 
were not toxic towards 3T3 and PBMC compared to doxorubicin which showed 
toxicity effects towards 3T3 and PBMC with the IC50 value of 3.0 µg/mL and 28.0 
µg/mL, respectively. The cell cycle analysis exhibited that damnacanthal exerted its 
toxicity effect towards HL-60 cells by inducing apoptosis with value of 25% after 72 
hours treatment.  
 
Immunomodulatory study revealed that damnacanthal, nordamnacanthal, betulinic acid 
and zerumbone were able to stimulate the proliferation of mice thymocytes, mice 
splenocytes and PBMC in a time and dose-dependent fashion. Damnacanthal and 
nordamnacanthal were able to stimulate the proliferation of mice thymocytes, mice 
splenocytes and PBMC even at low concentration (0.46 µg/mL) and did not cause 
inhibition at higher concentration (30 µg/mL). In contrast, betulinic acid and zerumbone 
showed inhibition at higher concentration (30 µg/mL) and proliferate well at lower 
concentration (7.5 µg/mL) towards those immune cells. Results obtained from cell cycle 
analysis exhibited that the proliferation effect of those compounds on PBMC were 
corresponding with the MTT based lymphocyte proliferation assay. Moreover, those 
compounds were demonstrated to induce immunoregulatory cytokine production in 
highest degree of human IL-2 and in lower degree of human IL-12 upon stimulation of 
PBMC in a time dependent manner. Based on the result presented, the compounds 
damnacanthal, nordamcanthal, betulinic acid and zerumbone can act as cytotoxic and 
immunomodulatory agent which are very useful in treating cancer and enhancing the 
immune system. 
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Kajian ini dilakukan adalah untuk menilai kesan ketoksikan dan pengawal imun 
daripada damnacanthal, nordamnacanthal, betulinic acid dan zerumbone yang 
diperolehi daripada tumbuhan ubatan tempatan ke atas jujukan-jujukan sel leukemia 
dan sel keimunan yang normal. Kajian ketoksikan telah dijalankan ke atas  HL-60 
(leukemia kronik promeilositik manusia), CEM-SS (leukemia T-limphoblastik 
manusia), WEHI-3B (Leukemia myelomonositik tikus), 3T3 (embrio fibroblast tikus) 
dan sel darah periferi manusia (PBMC) dengan menggunakan esei MTT dan analisis  
kitaran sel. Keputusan yang diperolehi secara signifikan menunjukkan damnacanathal 
telah merencat sel HL-60, CEM-SS dan WEHI-3B dengan nilai IC50 4.0 µg/mL, 8.0 
µg/mL dan 3.3µg/mL, masing-masing. Nordamnacanthal dan betulinic acid telah 
menunjukkan kesan perencatan yang tinggi terhadap CEM-SS dan HL-60 dengan 
nilai IC50 5.7 µg/mL  dan 5.0 µg/mL, masing-masing. Sebagai perbandingan, 
zerumbone telah mempamerkan kesan ketoksikan yang tinggi terhadap semua 
jujukan sel leukemia dengan nilai IC50 kurang daripada 10 µg/mL. Menariknya, 
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damnacanthal, nordamnacanthal dan betulinic acid tidak menunjukkan kesan 
ketoksikan ke atas 3T3 dan PBMC berbanding dengan doxorubicin yang 
menunjukkan kesan ketoksikan terhadap 3T3 dan PBMC dengan nilai IC50 3.0 
µg/mL dan 28.0 µg/mL, masing-masing. Kajian kitaran sel menunjukkan 
damnacanthal telah mempamerkan kesan sitotoksik ke atas HL-60 melalui 
pengaruhan apoptosis dengan nilai 25% selepas 72 jam rawatan.  
 
Kajian terhadap pengawal imun mendedahkan sebatian damnacanthal, 
nordamnacanthal, betulinic acid dan zerumbone berkeupayaan merangsang proliferasi 
timus tikus, limfa tikus dan PBMC bergantung pada masa dan dos tertentu. 
Damnacanthal dan nordamnacanthal berkeupayaan merangsang proliferasi timus tikus, 
limfa tikus dan PBMC  pada kepekatan yang rendah (0.46 µg/mL) serta tidak 
menyebabkan perencatan pada kepekatan yang tinggi (30 µg/mL). Berbanding dengan 
betulinic acid dan zerumbone, kedua-dua sebatian tersebut didapati merencat proliferasi 
timus tikus, limfa tikus dan PBMC pada kepekatan yang tinggi (30  µg/mL) dan 
berproliferasi dengan baik pada kepekatan (7.5 µg/mL) selepas 48 jam rawatan. 
Keputusan yang diperolehi daripada analisis kitaran sel mempamerkan kesan proliferasi 
daripada sebatian-sebatian tersebut terhadap PBMC adalah sejajar dengan esei MTT 
proliferasi limfosit. Malahan, sebatian-sebatian tersebut juga berkeupayaan 
mengaruhkan penghasilan immunoregulasi interleukin-2 manusia pada darjah yang 
tinggi dan penghasilan interleukin-12 manusia pada darjah yang rendah melalui 
stimulasi PBMC pada masa tertentu. Berdasarkan keputusan yang diperolehi sebatian-
sebatian damnacanthal, nordamnacanthal, betulinic acid dan zerumbone berkeupayaan 
bertindak sebagai agen sitotoksik dan immunomodulator yang begitu penting dalam 
merawat kanser dan meningkatkan sistem keimunan.  
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CHAPTER 1 
 
INTRODUCTION 
 
Plants have been recognized as the greatest source in the treatment of wide a variety 
of diseases since ancient times (Balunas and Kinghorn, 2005; Adriana et al., 2002). 
More interestingly, some of these plants are believed to enhance the immune system 
and at the same time might contribute to a reduction in cancer incidence in human. 
There are experimental evidences showed that some of chemopreventive agents 
derived from natural products such as curcumin and betulinic acid modulate the 
immune system (Zuco et al., 2002; Gao et al., 2004). The capability of some natural 
products inhibiting cancer cells through modulation of the immune system have 
provided a greatest alternative in solving toxic side effects towards healthy cells and 
suppression of the immune system of current chemotherapeutical drugs available 
today. Therefore, it is a worth while effort to identify substances particularly from 
natural products which have potential therapeutical activity in treating cancer as well 
as might enhance the immune system.  
 
The human immune system, despite having its own sophisticated defense 
mechanisms, is inferior to bacteria and viruses with respect to adaptability (Wagner, 
1999). Generally, the immune system can be defined as an intricate network of 
specialized tissues, organs, cells and chemicals. The main functions of immune 
system are responsible for self-recognition and helps defend the body against a wide 
variety of pathogens (Abbas and Licthman, 2003). Among of them, lymphocyte is 
one of the most important immune cells which play a vital role in body’s defence 
mechanism. According to Anazzetti et al. (2003), when considering the 
chometherapy side effects, it is very important to verify whether or not the drug 
shows a harmful effects against dividing normal cells particularly in proliferating of 
lymphocytes. Therefore, the capability of a drug to proliferate the lymphocytes is 
one of the most important immune function markers to avoid toxic side effects 
towards healthy cells and immune system. Fortunately, there are some mitogens 
derived from natural products have been recognized to stimulate the proliferation of 
lymphocytes naturally which might useful in enhancing the immune system.  
 
Beside lymphocytes, cytokines are soluble glycoproteins which are critically 
involved in the immune systems and showed to have diverse functions in normal 
humoral and T cell-mediated immune response. Changes in cytokines levels are 
accompanied by various pathological conditions which might cause unbalance in the 
immune system (Fulup et al., 2006). Interleukin-2 (IL-2) and interleukin-12 (IL-12) 
are some of the well known cytokines. IL-2, a T-cell growth factor play a pivotal 
role in activation and proliferation of most T cells, natural killer cells (NK) and B 
cells during certain phases of their responses (Bryan et al., 2006). IL-12 is a 
pleoitropic cytokines with important proinflammatory and immunoregulatory 
functions. The major biological activity of IL-12 is on T and NK cells in which it 
increases cytokine production, particularly IFN-γ production. Currently, both IL-2 
and IL-12 are used as natural adjuvants for cancer immunotherapy to help in 
activating and enhancing the immune response (Parmiani et al., 2000; Eva et al., 
2007). 
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A fully functioning immune system is one of the most important criteria for a 
healthy life. However, nowadays our immune system is increasingly exposed to 
detrimental effects due to immunosuppressive environmental consequences, 
unhealthy living, malnutrition, cancers and others chronic illness (Wagner, 1999; 
Keller et al., 2005). Moreover, current cancer therapeutic practices, such as 
chemotheraphy and radiotheraphy may also suppress the immune system. Therefore, 
this situation demands a compensatory mechanism in enhancing and maintaining our 
immune system. Presently, a wide variety of natural products from medicinal herbs 
were exhibited to have an immunomodulatory effects which are very useful in 
solving those problems.  
  
Immunomodulator is any substances that capable of modifying or regulating one or 
more immune system (Stanilove et al., 2005). This regulation is a normalization 
process. It has been applied in cancer therapy and immunological diseases (Kumar et 
al., 2005). Immunomodulators may include some bacterial products, plant derived 
substances and lymphokines (Wagner, 1999). These fundamental fields of 
immunomodulators are currently receiving inadequate attention. For that reason, a 
number of plant products are being investigated concurrently for anticancer and 
immune response modifying activity (Uphayay, 1997).  
 
Therefore, this present study was carried out to investigate the toxicity and 
immunomodulatory effects of natural pure compounds derived from our local 
medicinal plants. The compounds selected in this study were damnacanthal and 
nordamnacanthal which were isolated from Morinda elliptica, zerumbone which 
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was isolated from Zingiber zerumbet and betulinic acid which was isolated from 
Melalueca cajuputi. The objectives of this project were:- 
 
1) to study the toxicity effects of damnacanthal, nordamnacanthal, betulinic 
acid and zerumbones towards cancerous and non-cancerous cell lines, 
2) to investigate the immunomodulatory effects of damnacanthal, 
nordamnacanthal, betulinic acid and zerumbones on mice splenocytes, 
mice thymocytes and PBMC in vitro and 
 3) to evaluate the production of human IL-2 and human IL-12 upon    
                stimulation of PBMC by damnacanthal, nordamnacanthal, betulinic acid  
                and zerumbone. 
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